Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-19-006965
Filing Date
2019-08-02
Accepted
2019-08-02 16:21:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 48673
2 GRAPHIC g764780dsp1.jpg GRAPHIC 3465
3 GRAPHIC g764780dsp1a.jpg GRAPHIC 2175
  Complete submission text file 0000950123-19-006965.txt   57668
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations